SCHEDULE 13G

Company

ZyVersa Therapeutics, Inc.

Filed

July 18, 2023

Accession Number

0001079973-23-000982

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →